FRF-HHO: Early ovarian cancer prediction using explainable fuzzy random forest optimized by Harris Hawks algorithm

Ovarian cancer remains one of the most lethal gynecological malignancies, largely due to delayed diagnosis and the absence of reliable early screening tools. This study proposes an interpretable machine learning framework that integrates Fuzzy Random Forest (FRF) with Harris Hawks Optimization (HHO) for early ovarian cancer prediction using routine clinical data. The analysis was conducted on a publicly available dataset comprising 349 patient records with 51 clinical and biochemical features. To mitigate overfitting and data leakage, Recursive Feature Elimination with Cross-Validation (RFECV), preprocessing, and SMOTE–Tomek balancing were applied exclusively within the training data. A total of 31 relevant biomarkers were selected for model development. The HHO-optimized FRF achieved an accuracy of 94.12%, precision of 91.43%, recall of 96.07%, and an F1-score of 93.69%, outperforming several baseline ensemble and gradient boosting models evaluated under identical experimental conditions. Model interpretability was enhanced through SHAP and LIME analyses, which consistently identified AFP, HE4, CA125, and Age as influential predictors, aligning with established clinical knowledge. The high recall indicates strong sensitivity to cancer cases, an essential requirement for diagnostic support. Despite encouraging performance, the study is limited by its moderate sample size and a retrospective design. Consequently, the findings should be interpreted as preliminary. Future work will focus on validation using larger, multi-center cohorts and prospective studies to assess generalizability and clinical scalability. • Hybrid FRF-HHO model achieved 94.12% accuracy and 96.07% recall for early ovarian cancer prediction. • RFECV selected 31 key clinical biomarkers, improving diagnostic precision and reducing dimensionality. • Explainable AI (SHAP and LIME) revealed AFP, HE4, CA125, and Age as dominant diagnostic indicators. • Model demonstrated superior interpretability and reliability, outperforming existing ML frameworks statistically (p < 0.05).

Authors

Institutions

Publication Details

Journal
Advances in Biomarker Sciences and Technology
Published
2026-01-14
DOI
https://doi.org/10.1016/j.abst.2026.01.003
Primary Topic
Ovarian cancer diagnosis and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

FRF-HHO: Early ovarian cancer prediction using explainable fuzzy random forest optimized by Harris Hawks algorithm

Dipta Gomes, Mushfika Ikfat, K.M. Yeaser Arafat, Mahfujur Rahman et al.
Advances in Biomarker Sciences and Technology
Ovarian cancer diagnosis and treatment
article

FRF-HHO: Early ovarian cancer prediction using explainable fuzzy random forest optimized by Harris Hawks algorithm

Dipta Gomes, Mushfika Ikfat, K.M. Yeaser Arafat, Mahfujur Rahman, Kazi Tanvir, Md. Areful Amin, Ahmed Hossain
article en

Abstract

Ovarian cancer remains one of the most lethal gynecological malignancies, largely due to delayed diagnosis and the absence of reliable early screening tools. This study proposes an interpretable machine learning framework that integrates Fuzzy Random Forest (FRF) with Harris Hawks Optimization (HHO) for early ovarian cancer prediction using routine clinical data. The analysis was conducted on a publicly available dataset comprising 349 patient records with 51 clinical and biochemical features. To mitigate overfitting and data leakage, Recursive Feature Elimination with Cross-Validation (RFECV), preprocessing, and SMOTE–Tomek balancing were applied exclusively within the training data. A total of 31 relevant biomarkers were selected for model development. The HHO-optimized FRF achieved an accuracy of 94.12%, precision of 91.43%, recall of 96.07%, and an F1-score of 93.69%, outperforming several baseline ensemble and gradient boosting models evaluated under identical experimental conditions. Model interpretability was enhanced through SHAP and LIME analyses, which consistently identified AFP, HE4, CA125, and Age as influential predictors, aligning with established clinical knowledge. The high recall indicates strong sensitivity to cancer cases, an essential requirement for diagnostic support. Despite encouraging performance, the study is limited by its moderate sample size and a retrospective design. Consequently, the findings should be interpreted as preliminary. Future work will focus on validation using larger, multi-center cohorts and prospective studies to assess generalizability and clinical scalability. • Hybrid FRF-HHO model achieved 94.12% accuracy and 96.07% recall for early ovarian cancer prediction. • RFECV selected 31 key clinical biomarkers, improving diagnostic precision and reducing dimensionality. • Explainable AI (SHAP and LIME) revealed AFP, HE4, CA125, and Age as dominant diagnostic indicators. • Model demonstrated superior interpretability and reliability, outperforming existing ML frameworks statistically (p < 0.05).

Advances in Biomarker Sciences and TechnologyVol. 8
American International University-Bangladesh (BD)
Life in Land
Openalex Percentile: Top 90%
Ovarian cancer diagnosis and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.